Thyrocare Technologies
THYROCARE · Healthcare > Hospital & Healthcare Services · Chairman: A Velumani · MD: Dharmil Sheth · Listing date: May 10, 2016 · Employees: 1582 · Navi Mumbai · http://www.thyrocare.com

Stock Price vs Company Growth
1d
1.3%
1w
1.9%
1m
5.4%
3m
6.6%
6m
55.6%
1y
77.4%
5y
13.9%
all
7.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 957 1.3%
775
1,002
Company Overview

Sales
623 Cr
Growth: 9.2%
Profit after Tax
84 Cr
Growth: 8.2%
Small Cap
5,072 Cr
P/E: 60.6x
Industry P/E: 48.1x
Fundamentals

Sales (Cr) ₹ 623
Growth 9.2%
EBITDA 25.1%
P/S 8.1x
Dividend 3.6%
P/E 60.6x
Book Value ₹ 109
PEG Ratio 6.6x
ROE 15.0%
P/B 8.8x
Shareholding Pattern

Institutions
Arisaig Asia Consumer Fund Limited
6.11 %
Nippon Life India Trustee Ltd-A/C Nippon India Nifty Small Cap 250 Index Fund
3.57 %
Fundsmith Emerging Equities Trust Plc
1.46 %
Promoters
Dr.A.Velumani
28.02 %
Thyrocare Publications Llp
12.36 %
Thyrocare Properties And Infrastructure Private Imited
9.88 %
A.Sundararaju Huf
4.57 %
Sumathi Infra Project Llp
2.98 %
Others
Bakak Financial Securities
2.84 %
Llp
0.13 %
Increase    Decrease    No change
Company Profile Detailed

Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.
Investors (82)
Followers (22)